fbpx
Connect with us

Featured

Is healthcare progress stunted by data privacy laws?

Avatar photo

Published

on

Medical records are protected by law – but are restrictions on data sharing detrimental to the health of the population?

Michael Hughes, chief business officer at Duality, speaks to Health Tech World about how technology is improving the life of millions – by enabling medical data to be used confidentially… 

When going to the hospital, it is important that patients trust the providers of their healthcare – to treat what ails them, but also to treat them with respect and dignity.

This includes the use of their data.

We as patients expect that our sensitive information will be managed with the due care and respect it deserves, and within the confines of any consent we choose to provide. 

In the US alone, thousands of hospitals and research organisations, along with the different medical registries hold vast amounts of patient data.

These include genomic data, clinical data, patient disease registries and electronic heath registries, amongst others.

The idea that our health records are sensitive and should be protected is shared by governments across the world, which impose restrictions on its use through various regulations. 

Regulatory barriers affecting public health

While compliance is critical, the reality is that regulatory barriers – intended to protect patients – could be preventing vital work to improve the public’s health. 

The challenge is that healthcare research depends on the sharing of health-related data to advance understanding of illnesses and treatments.

Without the means to collaborate, it becomes difficult and often impossible for researchers to identify effective treatments for conditions like people with a genetic predisposition as well as determine the effectiveness of treatment measurements across hospital systems. 

The Health Insurance Portability and Accountability Act prevents firms in the US from disclosing patient details without consent, while in Europe, the EU’s General Data Protection Regulation requires data to stay within certain regional and other boundaries.  

Data privacy laws

This regulatory landscape is becoming increasingly complex.

Research and consultancy firm Gartner projects that by 2024, 75% of the world’s population’s personal data will be protected by privacy regulations. 

While legislation protects our data, it makes it more difficult for data collaboration between hospitals, pharmaceutical companies, and research firms to take place.

That’s because firms don’t have the privacy and security guarantees to share health data within the current regulatory environment.

Potential of data collaboration in health

If hospitals, pharmaceutical companies, and research firms could share and collaborate on data– there are endless possibilities to what can be achieved.

Combining different health data sets together could lead to major breakthroughs in healthcare and medicine. 

One area which would benefit would be clinical trials. Medical researchers would be able to access data to help them identify the right participants to fill their studies much more quickly.

This would reduce costs significantly and help researchers make faster breakthroughs in interventions and treatments.

Pharmaceutical companies would also be a major beneficiary. If these firms could get access to data, they would be able to improve their pharmacologic recipes, dramatically improving treatments for people with illnesses. 

Pharmaceutical companies often neglect ‘rare diseases’ due to funding constraints.

Rare diseases in a “significant” number of people

A ‘rare disease’ is defined as affecting up to 10% of the population, which could be 36 million people in the US or 6 million in the UK – and that is significant number of people, whose illnesses don’t get the required focus and research.

Through combining data, pharmaceutical companies may be able to research these ‘rare diseases’ more cost-effectively and in a way that wouldn’t otherwise be possible.

Through analysis of a wider pool of data, researchers could solve health problems for an individual before they are known.

They could discover certain predispositions to a form of cancer that the individual has yet to be diagnosed with. As such, healthcare providers can create an individualised life treatment plan, which could mean the person never actually encounters the disease. 

These examples highlight the massive benefit that data collaboration could bring to health research and care.

The necessity for data collaboration to take place while adhering to regulatory compliance has led to new strategies and the increased adoption of innovative technology.   

Tech to enable collaboration

Two key factors are now making data collaboration possible – technology and the formation of a data-driven C-suite, who have a responsibility for operationalising privacy requirements at leadership levels of firms. 

Privacy enhancing technologies (PETs) is a term that covers an array of such tools that allow firms to perform computations on encrypted data without ever decrypting it and, therefore, without revealing anything sensitive.

This means they can share and analyse sensitive data without exposing the underlying information. Crucially, this means that healthcare firms can stay within regulatory requirements while protecting confidentiality and intellectual property. 

There is growing and increasing awareness in the healthcare industry, and by regulators, that these technologies can truly preserve the privacy of data and the analysis being conducted.

These developments can pave the way for major advancements in health research and care.

By combining disparate health related data, we can change health and patient care around the world.

More research & more understanding

As more health research and care organisations use these privacy enhancing technologies, the more understanding we will have about our health.

This will have not only have cost effective benefits for the organisations and researchers but also the health of the whole population. 

Michael Hughes 

Don’t miss…

Cybercrime is not going away – is your business prepared?

Continue Reading
4 Comments

4 Comments

  1. Pingback: Occuity wins Tech Start-up of the Year at Business Magazine awards

  2. Pingback: Another Round appoints Jesse Shanahan as CTO - Health Tech World

  3. Pingback: At-home saliva test measures and explains mental health

  4. Pingback: IP of software in medical devices and what you can do to protect it

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories